VNB
GILD icon

Virginia National Bank’s Gilead Sciences GILD Stock Holding History

Virginia National Bank’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,325
Closed -$257K – 106
2018
Q3 		$257K Buy
+3,325
New +$251K 0.09% 97

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Virginia National Bank's GILD Position: Q4 2018 in Review

Virginia National Bank sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,325 shares — an estimated $257K sold.

Virginia National Bank first reported a position in GILD in Q3 2018 and held it in 1 quarter. The position peaked at $257K in Q3 2018. 1,497 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Virginia National Bank reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Virginia National Bank sold 3,325 Gilead Sciences shares in Q4 2018, an estimated $257K.
  • Virginia National Bank first reported a position in Gilead Sciences in Q3 2018 and held it in 1 quarter.
  • Virginia National Bank's Gilead Sciences position peaked at $257K in Q3 2018.
  • 1,497 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Virginia National Bank's 13F filing for Q4 2018, filed 24 Jan 2019.